- World rank, 2022–2025
- #16,182 of 28,054 · #19,346 all time
- Rank in Germany
- #632 of 1,178
- Research works
- 319 ▲ 23% vs 2013–17
- Citations
- 7.2k 22.4 per fractional work
- Top-10% rate
- 21.9% record average 16.5%
- Open access
- 44% world 28%
What is Pfizer (Germany) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Health SciencesDomain | #9,683 of 20,462 | 16.3% | 197 | |
| MedicineField | #9,744 of 17,978 | 16.7% | 182 |
Each strip is that field’s whole ranked pool, with the notch where Pfizer (Germany) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 8.8×. Every wedge is a field page.
- Immunology and Microbiology 8.8×
- Veterinary 4.8×
- Pharmacology, Toxicology and Pharmaceutics 4.0×
- Medicine 2.4×
- Economics, Econometrics and Finance 2.4×
- Biochemistry, Genetics and Molecular Biology 1.9×
- Mathematics 1.8×
- Health Professions 1.6×
- Computer Science 0.9×
- Chemistry 0.9×
- Decision Sciences 0.9×
- Materials Science 0.5×
- Chemical Engineering 0.4×
- Social Sciences 0.3×
- Arts and Humanities 0.3×
- Dentistry 0.2×
- Engineering 0.2×
- Business, Management and Accounting 0.1×
- Agricultural and Biological Sciences 0.1×
- Psychology 0.1×
- Neuroscience 0.0×
- Environmental Science 0.0×
Who are the top researchers at Pfizer (Germany)?
Ranked on the composite score, Djork-Arné Clevert, Christof von Eiff and J. Schiffner‐Rohe lead among researchers whose main affiliation is Pfizer (Germany).
- 1 Djork-Arné Clevert Germany · #135,421 worldwide 273 citations · 22 works
- 2 Christof von Eiff Germany · #357,602 worldwide 129 citations · 33 works
- 3 J. Schiffner‐Rohe Germany · #699,235 worldwide 59 citations · 15 works
- 4 Friedhelm Leverkus Germany · #1,353,034 worldwide 45 citations · 15 works
Which keywords describe research at Pfizer (Germany)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Machine Learning, Vaccine Development, Human Metapneumovirus, Respiratory Syncytial Virus, Pathogenesis, Public Health and Vaccine.
- Neoadjuvant Therapy
- Neisseria meningitidis
- Gene Therapy
- Infectious Diseases
- Health Equity
- Vaccine Hesitancy
- Precision Medicine
- Immunity
- Immune Response
- Cost-effectiveness Analysis
- Pneumococcal Conjugate Vaccine
- Community-Acquired Pneumonia
- Pandemic
- Medical Imaging
- Artificial Intelligence
- Healthcare
- Quality of Life
- Respiratory Syncytial Virus
- Vaccine Development
- Machine Learning
- Epidemiology
- Public Health
- Human Metapneumovirus
- Pathogenesis
- Clinical Practice Guidelines
- Vaccine
- Antimicrobial Resistance
- Medicinal Chemistry
- Respiratory Infections
- Molecular Docking
- Virtual Screening
- Health Utility Measures
- Pathogen Transmission
- Guidelines
- COVID-19 Vaccine
- Clinical Management
- SARS-CoV-2
- Bacterial Meningitis
- Molecular Characterization
- Clinical Decision Support
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology19▲ 6.1×37 topics
- Machine Learning8▲ 3.0×10 topics
- Public Health5▲ 4.2×10 topics
- Vaccine Development5▲ 24×3 topics
- Human Metapneumovirus4▲ 115×1 topic
- Respiratory Syncytial Virus4▲ 115×1 topic
- Pathogenesis4▲ 10×10 topics
- Quality of Life3▲ 3.1×8 topics
- Clinical Practice Guidelines3▲ 7.6×5 topics
- Healthcare3▲ 3.7×9 topics
- Vaccine3▲ 10×6 topics
- Artificial Intelligence3▲ 2.9×4 topics
- Antimicrobial Resistance3▲ 18×2 topics
- Medical Imaging3▲ 7.0×3 topics
- Medicinal Chemistry3▲ 13×2 topics
- Pandemic3▲ 3.2×5 topics
- Respiratory Infections3▲ 30×2 topics
- Community-Acquired Pneumonia3▲ 100×1 topic
- Molecular Docking3▲ 27×1 topic
- Pneumococcal Conjugate Vaccine3▲ 100×1 topic
- Virtual Screening3▲ 36×1 topic
- Cost-effectiveness Analysis2▲ 37×1 topic
- Health Utility Measures2▲ 37×1 topic
- Immune Response2▲ 5.5×8 topics
- Pathogen Transmission2▲ 44×2 topics
- Immunity2▲ 7.0×4 topics
- Guidelines2▲ 6.0×6 topics
- Precision Medicine2▲ 5.9×6 topics
- COVID-19 Vaccine2▲ 36×1 topic
- Vaccine Hesitancy2▲ 39×1 topic
- Clinical Management2▲ 14×2 topics
- Health Equity2▲ 9.3×3 topics
- SARS-CoV-22▲ 7.5×4 topics
- Infectious Diseases2▲ 7.0×4 topics
- Bacterial Meningitis2▲ 111×1 topic
- Gene Therapy2▲ 11×5 topics
- Molecular Characterization2▲ 12×2 topics
- Neisseria meningitidis2▲ 111×1 topic
- Clinical Decision Support2▲ 16×1 topic
- Neoadjuvant Therapy2▲ 9.1×3 topics
Which research topics does Pfizer (Germany) publish most on?
By volume in 2022–2025: Respiratory viral infections research, Pneumonia and Respiratory Infections, Computational Drug Discovery Methods and Health Systems, Economic Evaluations, Quality of Life.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Respiratory viral infections research Epidemiology 4 works
- 2 Pneumonia and Respiratory Infections Epidemiology 3 works
- 3 Computational Drug Discovery Methods Computational Theory and Mathematics 3 works
- 4 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
- 5 Vaccine Coverage and Hesitancy Health 2 works
- 6 Bacterial Infections and Vaccines Microbiology 2 works
- 7 Vector-borne infectious diseases Parasitology 2 works
- 8 Artificial Intelligence in Healthcare and Education Health Informatics 2 works
- 9 Bladder and Urothelial Cancer Treatments Surgery 1 works
- 10 COVID-19 Clinical Research Studies Infectious Diseases 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Pfizer (Germany)'s research output changed?
Output in 2018–2022 was 23% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Berlin
- Freie Universität Berlin
- Technische Universität Berlin
- Humboldt-Universität zu Berlin
- Charité - Universitätsmedizin Berlin
- Fritz Haber Institute of the Max Planck Society
- Federal Institute For Materials Research and Testing
- Fraunhofer Institute for Telecommunications, Heinrich Hertz Institute
- Robert Koch Institute
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.